VYNE Therapeutics Inc.
2.86
0.11 (4.00%)
At close: Jan 15, 2025, 12:46 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 424.00K 477.00K 14.76M 20.99M 443.00K 10.64M 4.58M 674.00K n/a
Cost of Revenue n/a n/a 3.35M 1.39M 350.00K n/a n/a n/a n/a
Gross Profit 424.00K 477.00K 11.41M 19.60M 93.00K 10.64M 4.58M 674.00K n/a
Operating Income -29.26M -34.30M -68.03M -113.47M -76.24M -54.53M -29.59M -14.33M -4.61M
Interest Income n/a n/a n/a n/a n/a 3.09M 517.00K 264.00K n/a
Pretax Income -27.87M -33.93M -73.78M -255.83M -73.70M -51.45M -29.08M -14.07M -4.61M
Net Income -28.45M -33.95M -73.33M -255.57M -70.46M -51.45M -29.08M -14.07M -4.61M
Selling & General & Admin 13.38M 16.39M 54.48M 89.54M 22.48M 12.19M 5.17M 3.75M 1.69M
Research & Development 16.31M 18.39M 24.96M 43.53M 53.76M 52.99M 29.01M 11.26M 2.92M
Other Expenses n/a 363.00K -135.00K 1.11M n/a n/a n/a n/a n/a
Operating Expenses 29.68M 34.77M 79.44M 133.08M 76.24M 65.17M 34.17M 15.01M 4.61M
Interest Expense n/a n/a 5.61M 4.39M 2.54M 3.09M 517.00K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 29.68M 34.77M 82.79M 134.47M 76.24M 65.17M 34.17M 15.01M 4.61M
Income Tax n/a 13.00K -448.00K -258.00K -3.24M 3.09M -8.00K n/a n/a
Shares Outstanding (Basic) 10.27M 3.19M 2.86M 1.80M 471.39K 300.95K 286.04K 160.27K 160.27K
Shares Outstanding (Diluted) 10.27M 3.19M 2.86M 1.80M 471.39K 300.95K 286.04K 160.27K 160.27K
EPS (Basic) -2.77 -10.65 -25.65 -141.9 -149.48 -170.94 -101.65 -87.78 -28.75
EPS (Diluted) -2.77 -10.65 -25.65 -141.9 -149.48 -170.94 -101.65 -87.78 -28.75
EBITDA -29.26M -34.22M -38.94M -251.09M -94.08M -54.53M -29.59M -14.33M -4.61M
Depreciation & Amortization n/a 72.00K 109.00K 341.00K 350.00K 22.00K 8.00K 4.00K n/a

Create Price Alert on VYNE

Your price alert will notify you when the stock price is above 2.86.

Add to Watchlist